Modalities
Sublingual Ketamine Troches & Lozenges
Sublingual ketamine made telehealth programs possible — and brought a new set of safety questions with it.
Medically reviewed by: Pending medical review(draft)Last updated: June 4, 2026Evidence: Synthesis of pharmacokinetic literature and clinical practice
Profile
- Bioavailability: ~17–30%, hold-time dependent.
- Onset: 10–20 minutes.
- Duration: 45–60 minutes for acute effects.
- Setting: clinic, KAP office, or at-home (telehealth).
Strengths
- Lower cost per session than IV/IM.
- Accessible via telehealth in many regions.
- Self-administered after training, with virtual support.
Trade-offs
- No real-time medical monitoring during at-home use.
- Higher variability in absorbed dose.
- Take-home supply raises diversion and misuse concerns.
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.